Camella Wilson

Vice President

2023 - Current

Senior Associate

2021 - 2022

Northpond Ventures is a multi-billion-dollar science-driven venture capital firm based in Cambridge, MA; San Francisco, CA; and Bethesda, MD. Northpond has consistently been named one of the most active lead life science investors in venture industry rankings. It is deeply engaged in the academic ecosystem, having founded The Laboratory for Bioengineering Research and Innovation at the Wyss Institute at Harvard University; launched the MIT-Northpond Program – Advancing Life Science & Engineering Innovation; launched the Northpond Laboratories — Program for Research and Innovation at Stanford Medicine; and sponsored a prize for women entrepreneurs at MIT. It has led or co-led over 60 financings over the past several years and sits on the board of the vast majority of these businesses.

Board Observer

2023

Board Observer

2022

Executive Committee Member

2022

Board Observer

2022

Investment Associate

2019 - 2021

OCV is a Los Angeles based venture fund that to date has raised ~$260M. OCV invests in, owns, and operates companies with differentiated technologies and compelling target markets, with the overriding objective of creating sustainable long-term value. As value-additive partners focused on innovation, operational efficiency, and sound management, we have a proven track record helping businesses realize their true potential. Our focus sectors include Life sciences & Healthcare, Information Technology, Cloud businesses, E-commerce, and Media & Telecommunications.

VC Investor

2019 - 2019

I joined Venture University's Investing internship (25 investors, <1% acceptance rate) to immerse myself in the investing and startup world and pursue my passion for advancing innovative technologies and scalable business models. In this role I, • Gained quality experience sourcing healthcare deals (reviewed 350+ opportunities) and conducting due diligence (evaluating markets, teams, business models and key metrics). • Conducted investment evaluations, participated in weekly Partners Meetings, presented investment recommendations to the Investment Committee • Invested in 5 early stage startups and built a large network across accelerators, angels, VC / PE investors, and strategic partners.

Consultant – Project Management | Quantitative & Qualitative Data Analysis

2016 - 2018

As part of collaborative teams, I worked on 2-4-month project engagements to help multi-million and multi-billion dollar client firms achieve strategic and operational goals including targeted cost reductions or revenue gains. My team’s work focused on identifying problem root causes and generating informed actionable solutions. These two years marked a real departure from my academic and scientific background. While previously I was always the expert in the room, here I learned how to quickly adapt and get up to speed on each client’s business context and challenges. BCG also proved a master class on tenacity and resourcefulness; I stretched well outside my normal skillset to deliver on project goals, such as on my very first assignment where I created, recorded, and edited a popular informational video despite zero prior related experience. HIGHLIGHTS: • Co-developed cost reduction roadmap that raised a healthcare company’s bottom line $700M. • Identified and bridged gaps to best-in-class performance of OTC drugs for a pharma conglomerate. • Partnered on new organization structure that shaved $53M off costs for a retail pharmacy client. • Co-created first regional multi-billion-dollar bid for 2 local economic development committees.

Catalyst Program Intern and Fellow – Translational Research | Scientific Literature Review

2014 - 2016

Worked with the Catalyst Program team focused on translating lab discoveries into clinical applications that improve public health. The program provides catalytic funding and strategic partnerships to support the development of UCSF discoveries with commercial potential. HIGHLIGHTS: • Contributed to due diligence process by evaluating scientific basis of translational research proposal and identifying key next steps for product and business development. • Helped raise program awareness by organizing an informational meeting for ~30 researchers and conducting interviews to create case studies to highlight the program’s success.

Post-Doctoral Fellow – Research Development | Scientific Outreach

2011 - 2016

I led research into the mechanisms of fatty liver disease, obesity, and insulin resistance. In this largely autonomous role, I also secured independent funding, published scientific literature, and presented at scientific conferences. HIGHLIGHTS: • Co-led research team that determined how growth hormone regulates lipid metabolism and presented findings at national and international conferences. • Determined viability of research articles and issued recommendations for or against publication. • Secured ~$100K, two-year grant from the American Heart Association to fund independent research. • Engaged healthcare industry experts and leaders as a speaker at conferences including AASLD Liver Meeting, Boston, MA (2014); Keystone Symposia Lipid Pathways in Disease, Dublin, Ireland (2014); and UCSF Liver Center Annual Symposium, San Francisco, CA (2014).